Molecular Cancer Therapeutics: Strategies for Drug Discovery and DevelopmentISBN: 978-0-471-43202-9
Hardcover
368 pages
April 2004
This is a Print-on-Demand title. It will be printed specifically to fill your order. Please allow an additional 15-20 days delivery time. The book is not returnable.
|
Dr. George C. Prendergast was a Benjamin Franklin Scholar at the University of Pennsylvania and graduated magna cum laude with distinction in biochemistry in 1983. He received an M.S. in molecular biophysics and biochemistry from Yale University in 1984 and a Ph.D. in molecular biology from Princeton University in 1989. He was an American Cancer Society Postdoctoral Fellow at the Howard Hughes Medical Institute at New York University and then Senior Research Biochemist at Merck and Co. before being appointed in 1993 to the faculty of The Wistar Institute. In 1995, Dr. Prendergast was recognized by an American Cancer Society Junior Faculty Award and he was named a Pew Scholar in the Biomedical Sciences. In 1999, Dr. Prendergast became Senior Director in the Cancer Research Group at DuPont Pharmaceuticals. In 2002, he was appointed a Senior Investigator at the Lankenau Institute for Medical Research, a biomedical institute affiliated with Thomas Jefferson University in Philadelphia. Dr. Prendergast is currently Senior Editor of Cancer Research, the leading journal in the field.